Pluripotency transcription factors in the pathogenesis of colorectal cancer and implications for prognosis

Papers of special note have been highlighted as: • of interest

References

• 1 Castellanos A, Vicente-Dueñas C, Campos-Sánchez E et al. Cancer as a reprogramming-like disease: implications in tumor development and treatment. Semin. Cancer Biol. 20(2), 93–97 (2010).
  Medline CASGoogle Scholar
• 2 Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc. Natl Acad. Sci. USA 100(7), 3983–3988 (2003).
  Medline CASGoogle Scholar
• 3 O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445(7123), 106–110 (2007).• A landmark paper describing colorectal cancer stem cells.
  MedlineGoogle Scholar
• 4 Yoo MH, Hatfield DL. The cancer stem cell theory: is it correct? Mol. Cells 26(5), 514–516 (2008).
  Medline CASGoogle Scholar
• 5 Malanchi I, Peinado H, Kassen D et al. Cutaneous cancer stem cell maintenance is dependent on β-catenin signaling. Nature 452(7187), 650–653 (2008).
  Medline CASGoogle Scholar
• 6 Krivtsov AV, Twomey D, Feng Z et al. Transformation from commited progenitor to leukemia stem cell initiated by MLL-AF9. Nature 442(7104), 818–822 (2006).
  Medline CASGoogle Scholar
• 7 Kheirelseid EAH, Miller N, Chang KH et al. Mismatch repair protein expression in colorectal cancer. J. Gastrointest. Oncol. 4(4), 397–408 (2013).
  Medline CASGoogle Scholar
• 8 Fanali C, Lucchetti D, Farina M et al. Cancer stem cells in colorectal cancer from pathogenesis to therapy: controversies and perspectives. World J. Gastroenterol. 20(4), 923–942 (2014).
  MedlineGoogle Scholar
• 9 Ren F, Sheng WQ, Du X. CD133: a cancer stem cells marker, is used in colorectal cancers. World J. Gastroenterol. 19(17), 2603–2611 (2013).
  Medline CASGoogle Scholar
• 10 Nagano O, Saya H. Mechanism and biological significance of CD44 cleavage. Cancer Sci. 95(12), 930–935 (2004).
  Medline CASGoogle Scholar
• 11 van der Gun BTF, Melchers LJ, Ruiters MHJ, de Leij LFMH, McLaughlin PMJ, Rots MG. EpCAM in carcinogenesis: the good, the bad or the ugly. Carcinogenesis 31(11), 1913–1921 (2010).
  Medline CASGoogle Scholar
• 12 Schuijers J, Clevers H. Adult mammalian stem cells: the role of Wnt, Lgr5 and R-spondins. EMBO J. 31(12), 2685–2696 (2012).
  Medline CASGoogle Scholar
• 13 Chen JZ, Wang S, Tang R et al. Cloning and identification of a cDNA that encodes a novel human protein with thrombospondin type I repeat domain, hPWTSR. Mol. Biol. Rep. 29(3), 287–292 (2002).
  Medline CASGoogle Scholar
• 14 Muraro MG, Mele V, Daster S et al. CD133⁺, CD166⁺CD44⁺, and CD24⁺CD44⁺ phenotypes fail to reliably identify cell populations with cancer stem cell functional features in established human colorectal cancer cell lines. Stem Cells Transl. Med. 1(8), 592–603 (2012).
  Medline CASGoogle Scholar
• 15 Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131(5), 861–872 (2007).• One of the first papers to describe reprogramming to pluripotency by exogenous factors.
  Medline CASGoogle Scholar
• 16 Anokye-Danso F, Trivedi CM, Juhr D et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8(4), 376–388 (2011).• Confirms the essential role of microRNAs in reprogramming.
  Medline CASGoogle Scholar
• 17 Stefanovic S, Pucéat M. L'octamanie continue. Le double jeu de OCT4. Med. Sci. 26(4), 411–416 (2010).
  Google Scholar
• 18 Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M. Oct4 is required for primordial germ cell survival. EMBO Rep. 5(11), 1078–1083 (2004).
  Medline CASGoogle Scholar
• 19 Stefanovic S, Abboud N, Désilets S, Nury D, Cowan C, Pucéat M. Interplay of Oct4 with Sox2 and Sox17: a molecular switch from stem cell pluripotency to specifying a cardiac fate. J. Cell Biol. 186(5), 665–673 (2009).
  Medline CASGoogle Scholar
• 20 Deb-Rinker P, Ly D, Jezierski A, Sikorska M, Walker PR. Sequential DNA methylation of the Nanog and Oct-4 upstream regions in human NT2 cells during neuronal differentiation. J. Biol. Chem. 280(8), 6257–6260 (2005).
  Medline CASGoogle Scholar
• 21 Sarkar A, Hochedlinger K. The Sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell 12(1), 15–30 (2013).
  Medline CASGoogle Scholar
• 22 Liu KC, Lin BS, Zhao M et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cell Signal. 25(5), 1264–1271 (2013).
  Medline CASGoogle Scholar
• 23 Wang ML, Chiou SH, Wu CW. Targeting cancer stem cells: emerging role of Nanog transcription factor. OncoTargets Ther. 6(S38114), 1207–1220 (2013).
  MedlineGoogle Scholar
• 24 Navarro P, Avner P. When X-inactivation meets pluripotency: an intimate rendezvous. FEBS Lett. 583(11), 1721–1727 (2009).
  Medline CASGoogle Scholar
• 25 Shi G, Jin Y. Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res. Ther. 1(39), 1–9 (2010).
  Google Scholar
• 26 Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development 136(14), 2311–2322 (2009).
  Medline CASGoogle Scholar
• 27 Yu HB, Kunarso G, Hong FH, Stanton LW. Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells. J. Biol. Chem. 284(45), 31327–31335 (2009).
  Medline CASGoogle Scholar
• 28 Dang CV. MYC on the path to cancer. Cell 149(1), 22–35 (2012).
  Medline CASGoogle Scholar
• 29 Knoepfler PS. Why Myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell 2(1), 18–21 (2008).
  Medline CASGoogle Scholar
• 30 Wei D, Kanai M, Huang S, Xie K. Emerging role of KLF4 in human gastrointestinal cancer. Carcinogenesis 27(1), 23–31 (2006).
  Medline CASGoogle Scholar
• 31 Ghaleb AM, Yang VW. The pathobiology of Krüppel-like factors in colorectal cancer. Curr. Colorectal Cancer Rep. 4(2), 59–64 (2008).
  MedlineGoogle Scholar
• 32 Hu R, Zuo Y, Zuo L et al. KLF4 expression correlates with the degree of differentiation in colorectal cancer. Gut Liver 5(2), 154–159 (2011).
  Medline CASGoogle Scholar
• 33 Yu T, Chen X, Zhang W et al. Krüppel-like Factor 4 regulates intestinal epithelial morphology and polarity. PLoS ONE 7(2), e32492 (2012).
  Medline CASGoogle Scholar
• 34 Leng Z, Tao K, Xia Q et al. Krüppel-like Factor 4 acts as an oncogene in colon cancer stem cell-enriched spheroid cells. PLoS ONE 8(2), e56082 (2013).
  Medline CASGoogle Scholar
• 35 Flandez M, Guilmeau S, Blache P, Augenlicht LH. KLF4 regulation in intestinal epithelial cell maturation. Exp. Cell Res. 314(20), 3712–3723 (2008).
  Medline CASGoogle Scholar
• 36 Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol. 22(9), 474–482 (2012).
  Medline CASGoogle Scholar
• 37 Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318(5858), 1917–1920 (2007).
  Medline CASGoogle Scholar
• 38 Johnson SM, Grosshans H, Shingara J et al. RAS is regulated by the let-7 microRNA family. Cell 120(5), 635–647 (2005).
  Medline CASGoogle Scholar
• 39 Svoboda P, Flemr M. The role of miRNAs and endogenous siRNAs in maternal-to-zygotic reprogramming and the establishment of pluripotency. EMBO Rep. 11(8), 590–597 (2010).
  Medline CASGoogle Scholar
• 40 Tokarz P, Blasiak J. The role of micro RNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment. Acta Biochim. Pol. 59(4), 467–474 (2012).• Reviews the role of microRNAs in pluripotency, specifically in colorectal cancer.
  Medline CASGoogle Scholar
• 41 Yan H, Xue G, Mei Q et al. Repression of the miR-17–92 cluster by p53 has an important function in hypoxia-induced apoptosis. EMBO J. 28(18), 2719–2732 (2009).
  Medline CASGoogle Scholar
• 42 Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17–92 clusters in the control of transforming growth factor β signalling. Cancer Res. 68(20), 8191–8194 (2008).
  Medline CASGoogle Scholar
• 43 Dews M, Fox JL, Hultine S et al. The Myc-miR-17–92 axis blunts TGFβ signalling and production of multiple TGFβ-dependent antiangiogenic factors. Cancer Res. 70(20), 8233–8246 (2010).
  Medline CASGoogle Scholar
• 44 Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61(5), 759–767 (1990).• A paper proposing a framework of molecular lesions in colorectal cancer.
  Medline CASGoogle Scholar
• 45 Voutsadakis IA. Pathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2. J. Cell. Mol. Med. 11(2), 252–285 (2007).
  Medline CASGoogle Scholar
• 46 Takahashi-Yanaga F, Kahn M. Targeting Wnt signaling: can we safely eradicate cancer stem cells? Clin. Cancer Res. 16(12), 3153–3162 (2010).
  Medline CASGoogle Scholar
• 47 He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 281(5382), 1509–1512 (1998).
  Medline CASGoogle Scholar
• 48 Li J, Li J, Chen B. Oct4 was a novel target of Wnt signalling pathway. Mol. Cell Biochem. 362(1–2), 233–240 (2012).Paper describing a connection of the Wnt pathway and Oct4 with implications for the association of colorectal carcinogenesis with pluripotency.
  Medline CASGoogle Scholar
• 49 Lee SH, Koo BS, Kim JM et al. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. J. Pathol. 234(1), 99–107 (2014).
  Medline CASGoogle Scholar
• 50 Ramachandran I, Ganapathy V, Gillies E et al. Wnt inhibitory factor 1 suppresses cancer stemness and induces cellular senescence. Cell Death Dis. 5(e1246), 1–12 (2014).
  Google Scholar
• 51 Ji J, Wei X, Wang Y. Embryonic stem cell markers Sox-2 and OCT4 expression and their correlation with WNT signal pathway in cervical squamous cell carcinoma. Int. J. Clin. Exp. Pathol. 7(5), 2470–2476 (2014).
  MedlineGoogle Scholar
• 52 Ombrato L, Lluis F, Cosma MP. Regulation of self-renewal and reprogramming by TCF factors. Cell Cycle 11(1), 39–47 (2012).
  Medline CASGoogle Scholar
• 53 Sokol SY. Maintaining embryonic stem cell pluripotency with Wnt signalling. Development 138(20), 4341–4350 (2011).
  Medline CASGoogle Scholar
• 54 Hikasa H, Sokol SY. Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2. J. Biol. Chem. 286(14), 12093–12100 (2011).
  Medline CASGoogle Scholar
• 55 Cole MF, Johnstone SE, Newman JJ, Kagey MH, Young RA. Tcf3 is an integral component of the core regulatory circuitry of embryonic stem cells. Genes Dev. 22(6), 746–755 (2008).
  Medline CASGoogle Scholar
• 56 Rennoll SA, Konsavage WM Jr, Yochum GS. Nuclear AXIN2 represses MYC gene expression. Biochem. Biophys. Res. Commun. 443(1), 217–222 (2014).
  Medline CASGoogle Scholar
• 57 Yook JI, Li XY, Ota I et al. A Wnt-Axin2-GSK3β cascade regulates Snail1 activity in breast cancer cells. Nat. Cell Biol. 8(12), 1398–1406 (2006).
  Medline CASGoogle Scholar
• 58 Han X, Fang X, Lou X et al. Silencing SOX2 induced mesenchymal–epithelial transition and its expression predicts liver and lymph node metastasis of CRC patients. PLoS ONE 7(8), e41335 (2012).
  Medline CASGoogle Scholar
• 59 Larue L, Bellacosa A. Epithelial–mesenchymal transition in development and cancer: role of phosphatidylinositol 3′ kinase/AKT pathways. Oncogene 24(50), 7443–7454 (2005).
  Medline CASGoogle Scholar
• 60 Schülein C, Eilers M, Popov N. PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity. FEBS Lett. 585(14), 2151–2157 (2011).
  Medline CASGoogle Scholar
• 61 Pon YL, Zhou HY, Cheung ANY, Ngan HY, Wong AS. p70 S6 kinase promotes epithelial to mesenchymal transition through Snail induction in ovarian cancer cells. Cancer Res. 68(16), 6524–6532 (2008).
  Medline CASGoogle Scholar
• 62 Ferraris L, Stewart AP, Kang J et al. Combinatorial binding of transcription factors in the pluripotency control regions of the genome. Genome Res. 21(7), 1055–1064 (2011).
  Medline CASGoogle Scholar
• 63 Gan B, Lim C, Chu G et al. FoxOs enforce a progression checkpoint to constrain m TORC1-activated renal tumorigenesis. Cancer Cell 18(5), 472–484 (2010).
  Medline CASGoogle Scholar
• 64 Lin Y, Yang Y, Li W et al. Reciprocal regulation of Akt and Oct4 promotes the self-renewal and survival of embryonal carcinoma cells. Mol. Cell 48(4), 627–640 (2012).
  Medline CASGoogle Scholar
• 65 Adorno M, Cordenonsi M, Montagner M et al. A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis. Cell 137(1), 87–98 (2009).
  Medline CASGoogle Scholar
• 66 Kim M, Choe S. BMPs and their clinical potentials. BMB Rep. 44(10), 619–634 (2011).
  Medline CASGoogle Scholar
• 67 Bertrand FE, Angus CW, Partis WJ, Sigounas G. Developmental pathways in colon cancer. Crosstalk between WNT, BMP, Hedgehog and Notch. Cell Cycle 11(23), 1–8 (2012).
  MedlineGoogle Scholar
• 68 Freeman TJ, Smith JJ, Chen X et al. Smad4-mediated signalling inhibits intestinal neoplasia by inhibiting expression of β-catenin. Gastroenterology 142(3), 562–571 (2012).
  Medline CASGoogle Scholar
• 69 Lee MK, Pardoux C, Hall MC et al. TGF-β activates Erk MAP kinase signalling through direct phosphorylation of ShcA. EMBO J. 26(17), 3957–3967 (2007).
  Medline CASGoogle Scholar
• 70 Voorneveld PW, Kodach LL, Jacobs RJ et al. Loss of SMAD4 alters BMP signalling to promote colorectal cancer cell metastasis via activation of Rho and ROCK. Gastroenterology 147(1), 196–208 (2014).
  Medline CASGoogle Scholar
• 71 Scheel C, Weinberg RA. Cancer stem cells and epithelial–mesenchymal transition: concepts and molecular links. Semin. Cancer Biol. 22(5–6), 396–403 (2012).
  Medline CASGoogle Scholar
• 72 Menendez S, Camus S, Izpisua Belmonte JC. p53 guardian of reprogramming. Cell Cycle 9(19), 3887–3891 (2010).
  Medline CASGoogle Scholar
• 73 Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 137(3), 413–431 (2009).
  Medline CASGoogle Scholar
• 74 Olsson A, Manzl C, Strasser A, Villunger A. How important are post-translational modifications in p53 for selectivity in target-gene transcription and tumour suppression? Cell Death Differ. 14(9), 1561–1575 (2007).
  Medline CASGoogle Scholar
• 75 Kawamura T, Suzuki J, Wang YV et al. Linking the p53 tumor suppressor pathway to somatic cell reprogramming. Nature 460(7259), 1140–1144 (2009).
  Medline CASGoogle Scholar
• 76 Marión RM, Strati K, Li H et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460(7259), 1149–1153 (2009).• Studies show p53 inhibits pluripotency as part of tumor-suppressing properties.
  Medline CASGoogle Scholar
• 77 Hermeking H. MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat. Rev. Cancer 12(9), 613–626 (2012).
  Medline CASGoogle Scholar
• 78 Tutlewska K, Lubinski J, Kurzawski G. Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review. Hereditary Cancer Clin. Pract. 11(9), 1–9 (2013).
  MedlineGoogle Scholar
• 79 Kodach LL, Wiercinska E, De Miranda NFCC et al. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers. Gastroenteroloy 134(5), 1332–1341 (2008).
  Medline CASGoogle Scholar
• 80 Padín-Iruegas M-E, Herranz-Carnero M, Aguin-Losada S et al. Prognostic value of changes in the expression of stem cell markers in the peripheral blood of patients with colon cancer. Oncol. Rep. 29(6), 2467–2472 (2013).
  Medline CASGoogle Scholar
• 81 Neumann J, Bahr F, Horst D et al. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer. BMC Cancer 11(518), 1–7 (2011).
  MedlineGoogle Scholar
• 82 Saigusa S, Tanaka K, Toiyama Y et al. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemorediotherapy. Ann. Surg. Oncol. 16(12), 3488–3498 (2009).
  MedlineGoogle Scholar
• 83 Xu F, Dai C, Zhang R, Zhao Y, Peng S, Jia C. Nanog: a potential biomarker for liver metastasis of colorectal cancer. Dig. Dis. Sci. 57(9), 2340–2346 (2012).
  Medline CASGoogle Scholar
• 84 Toon CW, Chou A, Clarkson A et al. Immunohistochemistry for Myc predicts survival in colorectal cancer. PLoS ONE 9(2), e87456 (2014).
  MedlineGoogle Scholar
• 85 Smith DR, Goh HS. Overexpression of the c-myc proto-oncogene in colorectal carcinoma is associated with a reduced mortality that is abrogated by point mutation of the p53 tumor suppressor gene. Clin. Cancer Res. 2(6), 1049–1053 (1996).
  MedlineGoogle Scholar
• 86 Takatsuno Y, Mimori K, Yamamoto K et al. The rs6983267 SNP is associated with MYC transcription efficiency, which promotes progression and worsens prognosis of colorectal. Ann. Surg. Oncol. 20(4), 1395–1402 (2013).
  MedlineGoogle Scholar
• 87 Daraei A, Salehi R, Salehi M et al. Effect of rs6983267 polymorphism in the 8q24 region and rs4444903 polymorphism in EGF gene on the risk of sporadic colorectal cancer in Iranian population. Med. Oncol. 12(2), 1044–1049 (2011).
  Google Scholar
• 88 King CE, Cuatrecasas M, Castells A, Sepulveda AR, Lee JS, Rustgi AK. LIN28B promotes colon cancer progression and metastasis. Cancer Res. 71(12), 4260–4268 (2011).• Together with references 80 to 85 describes association of pluripotency core factors with prognosis of colorectal cancer.
  Medline CASGoogle Scholar
• 89 Patel NV, Ghaleb AM, Nandan MO, Yang VW. Expression of the tumor suppressor Krüppel-like Factor 4 as a prognostic predictor for colorectal cancer. Cancer Epidemiol. Biomarkers Prev. 19(10), 2631–2638 (2010).
  Medline CASGoogle Scholar
• 90 Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat. Genet. 24(4), 372–376 (2000).
  Medline CASGoogle Scholar
• 91 Webber EM, Lin JS, Whitlock EP. Oncotype Dx tumor gene expression profiling in stage II colon cancer. PLoS Curr. 2(2), RRN1177 (2010).
  MedlineGoogle Scholar
• 92 Martin-Belmonte F, Perez-Moreno M. Epithelial cell polarity, stem cells and cancer. Nat. Rev. Cancer 12(1), 23–36 (2012).
  CASGoogle Scholar
• 93 Voutsadakis IA. The ubiquitin–proteasome system and signal transduction pathways regulating epithelial mesenchymal transition of cancer. J. Biomed. Sci. 19(67), 1–13 (2012).
  MedlineGoogle Scholar
• 94 Burguignon LYW, Wong G, Earle C, Chen L. Hyaluronan–CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J. Biol. Chem. 287(39), 32800–32824 (2010).
  Google Scholar
• 95 Jachin S, Bae JS, Sung JJ et al. The role of nuclear EpICD in extrahepatic cholangiocarcinoma: association with β-catenin. Int. J. Oncol. 45(2), 691–698 (2014).
  Medline CASGoogle Scholar
• 96 Huang HP, Chen PH, Yu CY et al. Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming. J. Biol. Chem. 286(38), 33520–33532 (2011).
  Medline CASGoogle Scholar
• 97 Hao HX, Xie Y, Zhang Y et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner. Nature 485(7397), 195–200 (2012).
  Medline CASGoogle Scholar